DOSSIER · 13F-HR · Q2 2026

HEIGHTS CAPITAL MANAGEMENT, INC

$433M in tracked AUM across 323 positions as of Q2 2026.

HC
CIK 0001081698 · last filed Jun 30, 2026
Total AUM
$433M
as of Q2 2026
Holdings
323
positions
Whale Score
53
53
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026
Portfolio Overview

Heights Capital Management reports a 13F portfolio valued at $351.0 million as of 2025-09-30, composed of 182 reported holdings. The portfolio is highly concentrated: the top 2 positions account for $124.67 million (35.5% of the portfolio) and the top 10 positions total $196.53 million (56.0%). The top 50 holdings represent roughly 87.8% of the portfolio, leaving about $42.97 million (12.2%) spread across the remaining 132 smaller positions. The filing also shows a reporting...

Key Holdings and Their Significance
  • FLUTTER ENTMT PLC (21.29%, $74.72M): The single largest position and the primary driver of portfolio performance. With over one-fifth of assets in this single equity, portfolio returns and risk will be materially influenced by Flutter’s operating results, regulatory environment for online gambling, and FX exposure (U.K./international operations).
  • NNE / NANO NUCLEAR ENERGY INC (14.23%, $49.95M): The second-largest holding and the largest position categorized in Utilities. At 14.2% of the portfolio, this position also materially affects portfolio volatility; it represents a large single-company exposure in a specialized energy/technology niche.
  • IBRX / IMMUNITYBIO INC (4.60%, $16.15M) and OATLY GROUP AB (3.06%, $10.73M): Secondary meaningful exposures in healthcare/biotech and consumer food-tech respectively. These are smaller than the top two but still represent active high-idiosyncratic risk bets.
  • Other material positions (positions #5–#10 totaling ~$60.4M, ~17.2%): These include a mix of microcap and special-purpose entities (see SPACs below). No single one outside the top two exceeds ~4.6% of the portfolio.

Concentration takeaway: roughly 36% of portfolio value sits in two names; 56% in the top 10. This is an active, concentrated portfolio where a small number of holdings dominate risk/return.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
G3643J108
FLUTTER ENTMT PLC
$30M294K6.9%
02
AMC
AMC ENTMT HLDGS INC
$24M12.6M5.5%
03
G59665102
MEIRAGTX HLDGS PLC
$11M850K2.7%
04
TSHA
TAYSHA GENE THERAPIES INC
$10M1.5M2.4%
05
G8443M128
STARLINK AI ACQUISITION CORP
$10M1000K2.3%
06
G2104X101
CH4 NATURAL SOLUTIONS CORP
$8M800K1.8%
07
G4992A110
JACKSON ACQUISITION CO II
$7M700K1.7%
08
G50004129
JAB ACQUISITION CORP I
$7M700K1.6%
09
G2847J104
DRUGS MADE IN AMER ACQUTN CO
$7M648K1.6%
10
G8976D107
TOYO CO LTD
$7M989K1.6%

Filing history

2026Q2Jun 30
$433M 20.7%
323 positionsView →
2026Q1Mar 31
$359M 28.7%
265 positionsView →
2025Q4Dec 31
$279M 20.6%
192 positionsView →
2025Q3Sep 30
$351M 6.3%
182 positionsView →
2025Q2Jun 30
$375M 75.9%
162 positionsLocked
2025Q1Mar 31
$213M 5.3%
129 positionsLocked
2024Q4Dec 31
$202M 50.0%
146 positionsLocked
2024Q3Sep 30
$135M
138 positionsLocked